These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31558335)

  • 1. Development of an academic disease registry for spinal muscular atrophy.
    Mercuri E; Finkel R; Scoto M; Hall S; Eaton S; Rashid A; Balashkina J; Coratti G; Pera MC; Samsuddin S; Civitello M; Muntoni F;
    Neuromuscul Disord; 2019 Oct; 29(10):794-799. PubMed ID: 31558335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study Design.
    Finkel RS; Day JW; De Vivo DC; Kirschner J; Mercuri E; Muntoni F; Shieh PB; Tizzano E; Desguerre I; Quijano-Roy S; Saito K; Droege M; Dabbous O; Khan F; Renault L; Anderson FA; Servais L
    J Neuromuscul Dis; 2020; 7(2):145-152. PubMed ID: 32039859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A National Spinal Muscular Atrophy Registry for Real-World Evidence.
    Hodgkinson VL; Oskoui M; Lounsberry J; M'Dahoma S; Butler E; Campbell C; MacKenzie A; McMillan HJ; Simard L; Vajsar J; Brais B; Chapman KM; Chrestian N; Crone M; Dobrowolski P; Dojeiji S; Dowling JJ; Dupré N; Genge A; Gonorazky H; Hasal S; Izenberg A; Johnston W; Leung E; Lochmüller H; Mah JK; Marerro A; Massie R; McAdam L; McCormick A; Melanson M; Mezei MM; Nguyen CE; O'Connell C; O'Ferrall EK; Pfeffer G; Phan C; Plamondon S; Poulin C; Rodrigue X; Schellenberg KL; Selby K; Sheriko J; Shoesmith C; Smith G; Taillon M; Taylor S; Warman Chardon J; Worley S; Korngut L
    Can J Neurol Sci; 2020 Nov; 47(6):810-815. PubMed ID: 32493524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy.
    Pechmann A; König K; Bernert G; Schachtrup K; Schara U; Schorling D; Schwersenz I; Stein S; Tassoni A; Vogt S; Walter MC; Lochmüller H; Kirschner J
    Orphanet J Rare Dis; 2019 Jan; 14(1):18. PubMed ID: 30665421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
    Ambrosini A; Calabrese D; Avato FM; Catania F; Cavaletti G; Pera MC; Toscano A; Vita G; Monaco L; Pareyson D
    Orphanet J Rare Dis; 2018 Oct; 13(1):176. PubMed ID: 30286784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Prospective Real-World Data Clinical Registry of Children and Adolescents With Migraine.
    Hornik CP; Gelfand AA; Szperka CL; Pezzuto T; Utevsky A; Kessel S; McCune S; Alexander JJ; Benjamin DK; Cohen-Wolkowiez M
    Headache; 2020 Feb; 60(2):405-415. PubMed ID: 31758549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal Muscular Atrophy: Past, Present, and Future.
    Ross LF; Kwon JM
    Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The SMA France national registry: already encouraging results].
    Lemoine M; Gomez M; Grimaldi L; Urtizberea JA; Quijano-Roy S
    Med Sci (Paris); 2021 Nov; 37 Hors série n° 1():25-29. PubMed ID: 34878390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy.
    Ke Q; Zhao ZY; Mendell JR; Baker M; Wiley V; Kwon JM; Alfano LN; Connolly AM; Jay C; Polari H; Ciafaloni E; Qi M; Griggs RC; Gatheridge MA
    World J Pediatr; 2019 Jun; 15(3):219-225. PubMed ID: 30904991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on Spinraza (Nusinersen) Treatment Study: Views of Individuals and Parents of Children Diagnosed with Spinal Muscular Atrophy.
    Pacione M; Siskind CE; Day JW; Tabor HK
    J Neuromuscul Dis; 2019; 6(1):119-131. PubMed ID: 30594933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of neuromuscular diseases and spinal muscular atrophy in Latin America.
    Monges S; Rosa AL
    Gene Ther; 2017 Sep; 24(9):578-580. PubMed ID: 28753203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and clinical management of spinal muscular atrophy.
    Han JJ; McDonald CM
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):661-80, xii. PubMed ID: 18625423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revised upper limb module for spinal muscular atrophy: Development of a new module.
    Mazzone ES; Mayhew A; Montes J; Ramsey D; Fanelli L; Young SD; Salazar R; De Sanctis R; Pasternak A; Glanzman A; Coratti G; Civitello M; Forcina N; Gee R; Duong T; Pane M; Scoto M; Pera MC; Messina S; Tennekoon G; Day JW; Darras BT; De Vivo DC; Finkel R; Muntoni F; Mercuri E
    Muscle Nerve; 2017 Jun; 55(6):869-874. PubMed ID: 27701745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical practice guidelines for spinal muscular atrophy].
    Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Pan J; Tan H; Zhou M; Liang D; Wu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):263-268. PubMed ID: 32128742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatments in spinal muscular atrophy: an overview of currently available data.
    Ramdas S; Servais L
    Expert Opin Pharmacother; 2020 Feb; 21(3):307-315. PubMed ID: 31973611
    [No Abstract]   [Full Text] [Related]  

  • 17. The prevalence of muscular dystrophy and spinal muscular atrophy in Croatia: data from national and non-governmental organization registries.
    Draušnik Ž; Cerovečki I; Štefančić V; Mihel S; Stevanović R; Barišić N; Matković H; Melša M; Mirić M; Pjevač N; Benjak T
    Croat Med J; 2019 Dec; 60(6):488-493. PubMed ID: 31894913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal muscular atrophy: diagnosis and management in a new therapeutic era.
    Arnold WD; Kassar D; Kissel JT
    Muscle Nerve; 2015 Feb; 51(2):157-67. PubMed ID: 25346245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for spinal muscular atrophy: SMN and beyond.
    Bowerman M; Becker CG; Yáñez-Muñoz RJ; Ning K; Wood MJA; Gillingwater TH; Talbot K;
    Dis Model Mech; 2017 Aug; 10(8):943-954. PubMed ID: 28768735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community.
    Cruz R; Belter L; Wasnock M; Nazarelli A; Jarecki J
    Clin Ther; 2019 May; 41(5):943-960.e4. PubMed ID: 31056304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.